Mineral Resources (MRL) has signed a binding agreement with Albemarle to divest a 50% stake in the Wodgina lithium project located in Western Australia for US$1.2 billion.
The companies have also set up a lithium joint venture and signed an exclusivity agreement for the deal.
The transaction will allow Albemarle to purchase a 50% interest in the Wodgina project that comprises tenements, assets, and related infrastructure.
Excluded from the agreement at Wodgina are mineral rights to iron ore, which would be retained exclusively by MRL, and tantalum, which would remain held by a third party.
After closing of the acquisition and completion of the construction and ramp-up of the spodumene concentration plant, Wodgina is expected to produce approximately 100,000 tonnes per year of lithium carbonate equivalent (LCE). This is planned to be used as feedstock for the future lithium hydroxide plant.
The parties would jointly fund, design, build, and operate a battery-grade lithium hydroxide plant to be constructed at Wodgina in two stages of up to 50,000 tonnes a year of LCE each.
Full Content: Metal Bulletin
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Live Nation Under Criminal Antitrust Investigation Over Pandemic-Era Refund Policies
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas